• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性肾脏病黑人患者矿物质代谢紊乱的患病率及严重程度

Prevalence and severity of disordered mineral metabolism in Blacks with chronic kidney disease.

作者信息

Gutiérrez O M, Isakova T, Andress D L, Levin A, Wolf M

机构信息

Department of Medicine, Renal Unit, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02114, USA.

出版信息

Kidney Int. 2008 Apr;73(8):956-62. doi: 10.1038/ki.2008.4. Epub 2008 Feb 6.

DOI:10.1038/ki.2008.4
PMID:18256597
Abstract

Disorders of mineral metabolism develop early in chronic kidney disease, but it appears that Blacks with stage-5 disease have more severe secondary hyperparathyroidism than other races. We measured levels of parathyroid hormone, calcium, phosphorus, 25-hydroxyvitamin D (25D) and 1,25-dihydroxyvitamin D (1,25D) in 227 Black and 1633 non-Black participants in the SEEK study, a multi-center cohort of patients with early chronic kidney disease. Overall, Blacks had similar 1,25D levels compared with non-Blacks, but significantly lower levels of 25D with higher levels of calcium, phosphorus, and parathyroid hormone, and were significantly more likely to have hyperphosphatemia than non-Blacks. In multivariable analyses adjusted for age, gender, estimated glomerular filtration rate, body mass index, and diabetes, Blacks had significantly lower 25D and higher parathyroid hormone levels than non-Blacks, with the latter parameter remaining significant after further adjustment for calcium, phosphorus, 25D, and 1,25D. The association between Black race and secondary hyperparathyroidism, independent of known risk factors, suggests that novel mechanisms contribute to secondary hyperparathyroidism in Blacks with chronic kidney disease.

摘要

矿物质代谢紊乱在慢性肾脏病早期就会出现,但似乎5期疾病的黑人比其他种族有更严重的继发性甲状旁腺功能亢进。我们在SEEK研究的227名黑人参与者和1633名非黑人参与者中测量了甲状旁腺激素、钙、磷、25-羟维生素D(25D)和1,25-二羟维生素D(1,25D)的水平,SEEK研究是一个早期慢性肾脏病患者的多中心队列研究。总体而言,与非黑人相比,黑人的1,25D水平相似,但25D水平显著较低,钙、磷和甲状旁腺激素水平较高,且黑人发生高磷血症的可能性显著高于非黑人。在对年龄、性别、估计肾小球滤过率、体重指数和糖尿病进行校正的多变量分析中,黑人的25D水平显著低于非黑人,甲状旁腺激素水平高于非黑人,在进一步对钙、磷、25D和1,25D进行校正后,后一参数仍具有显著性。黑人种族与继发性甲状旁腺功能亢进之间的关联独立于已知危险因素,这表明新的机制导致了慢性肾脏病黑人患者的继发性甲状旁腺功能亢进。

相似文献

1
Prevalence and severity of disordered mineral metabolism in Blacks with chronic kidney disease.慢性肾脏病黑人患者矿物质代谢紊乱的患病率及严重程度
Kidney Int. 2008 Apr;73(8):956-62. doi: 10.1038/ki.2008.4. Epub 2008 Feb 6.
2
Disordered FGF23 and mineral metabolism in children with CKD.慢性肾脏病儿童中紊乱的成纤维细胞生长因子 23 和矿物质代谢。
Clin J Am Soc Nephrol. 2014 Feb;9(2):344-53. doi: 10.2215/CJN.05840513. Epub 2013 Dec 5.
3
The prevalence of hypovitaminosis D and secondary hyperparathyroidism in obese Black Americans.肥胖美国黑人中维生素D缺乏症和继发性甲状旁腺功能亢进症的患病率。
Clin Endocrinol (Oxf). 2006 May;64(5):523-9. doi: 10.1111/j.1365-2265.2006.02502.x.
4
Vitamin D deficiency and anemia in early chronic kidney disease.维生素 D 缺乏和慢性肾脏病早期贫血。
Kidney Int. 2010 Apr;77(8):715-20. doi: 10.1038/ki.2009.551. Epub 2010 Feb 3.
5
Current recommended 25-hydroxyvitamin D targets for chronic kidney disease management may be too low.目前推荐的用于慢性肾脏病管理的25-羟基维生素D目标值可能过低。
J Nephrol. 2016 Feb;29(1):63-70. doi: 10.1007/s40620-015-0186-0. Epub 2015 Mar 4.
6
Race is a major determinant of secondary hyperparathyroidism in uremic patients: comparative study of Blacks and Hispanics.种族是尿毒症患者继发性甲状旁腺功能亢进的主要决定因素:黑人和西班牙裔的比较研究。
Clin Nephrol. 2008 Oct;70(4):312-8. doi: 10.5414/cnp70312.
7
Contribution of calcium, phosphorus and 25-hydroxyvitamin D to the excessive severity of secondary hyperparathyroidism in African-Americans with CKD.钙、磷和 25-羟维生素 D 对非裔美国人 CKD 患者继发性甲状旁腺功能亢进症严重程度的影响。
Nephrol Dial Transplant. 2012 Jul;27(7):2847-53. doi: 10.1093/ndt/gfs080. Epub 2012 Apr 13.
8
Posterior urethral valves: Metabolic consequences in a cohort of patients.后尿道瓣膜:一组患者的代谢后果
J Pediatr Urol. 2015 Aug;11(4):216.e1-6. doi: 10.1016/j.jpurol.2015.04.022. Epub 2015 Jun 4.
9
Rationale for Raising Current Clinical Practice Guideline Target for Serum 25-Hydroxyvitamin D in Chronic Kidney Disease.提高慢性肾脏病患者血清 25-羟维生素 D 现行临床实践指南靶目标的理由。
Am J Nephrol. 2019;49(4):284-293. doi: 10.1159/000499187. Epub 2019 Mar 15.
10
Racial differences in markers of mineral metabolism in advanced chronic kidney disease.晚期慢性肾脏病矿物质代谢标志物的种族差异。
Clin J Am Soc Nephrol. 2012 Apr;7(4):640-7. doi: 10.2215/CJN.07020711. Epub 2012 Mar 1.

引用本文的文献

1
Calcimimetic Prescriptions in Fee-for-Service Medicare Beneficiaries Undergoing Dialysis.接受透析的按服务收费的医疗保险受益人的拟钙剂处方情况。
JAMA Health Forum. 2025 Apr 4;6(4):e250452. doi: 10.1001/jamahealthforum.2025.0452.
2
Ethnic and seasonal variations in FGF-23 and markers of chronic kidney disease-mineral and bone disorder.成纤维细胞生长因子-23(FGF-23)以及慢性肾脏病-矿物质和骨异常标志物的种族和季节差异。
Clin Kidney J. 2024 Jun 20;17(7):sfae188. doi: 10.1093/ckj/sfae188. eCollection 2024 Jul.
3
Estimating the global prevalence of secondary hyperparathyroidism in patients with chronic kidney disease.
估算慢性肾脏病患者继发性甲状旁腺功能亢进症的全球患病率。
Front Endocrinol (Lausanne). 2024 Jun 21;15:1400891. doi: 10.3389/fendo.2024.1400891. eCollection 2024.
4
Black patients are more likely to undergo parathyroidectomy for secondary hyperparathyroidism.黑人患者更有可能因继发性甲状旁腺功能亢进而接受甲状旁腺切除术。
Surgery. 2023 Jan;173(1):111-116. doi: 10.1016/j.surg.2022.05.040. Epub 2022 Oct 1.
5
Fibroblast Growth Factor 23 (FGF 23) and intact parathyroid hormone (iPTH) as markers of mineral bone disease among Nigerians with non-diabetic kidney disease.成纤维细胞生长因子 23(FGF23)和全段甲状旁腺激素(iPTH)作为非糖尿病肾病患者矿物质骨病的标志物。
Afr Health Sci. 2022 Mar;22(1):344-351. doi: 10.4314/ahs.v22i1.42.
6
Modulation of cardiometabolic risk and CardioRenal syndrome by oral vitamin D supplementation in Black and White Southern Sahara residents with chronic kidney disease Stage 3: focus on racial and ethnic disparities.口服维生素 D 补充剂对黑人和撒哈拉沙漠南部白人慢性肾脏病 3 期患者的心血肾代谢风险和心血管肾综合征的调节:关注种族和民族差异。
Ren Fail. 2022 Dec;44(1):1243-1262. doi: 10.1080/0886022X.2022.2106244.
7
Oral Cholecalciferol Supplementation in Sahara Black People with Chronic Kidney Disease Modulates Cytokine Storm, Oxidative Stress Damage and Athero-Thromboembolic Risk.沙哈拉黑人群体慢性肾脏病患者口服胆钙化醇补充剂可调节细胞因子风暴、氧化应激损伤和动脉血栓栓塞风险。
Nutrients. 2022 May 29;14(11):2285. doi: 10.3390/nu14112285.
8
The Risk of Tuberculosis Infection in Non-dialysis Chronic Kidney Disease Patients.非透析慢性肾脏病患者的结核病感染风险
Front Med (Lausanne). 2021 Aug 13;8:715010. doi: 10.3389/fmed.2021.715010. eCollection 2021.
9
Racial differences in the relationship between high-normal 25-hydroxy vitamin d and parathyroid hormone levels in early stage chronic kidney disease.高正常 25-羟维生素 D 与早期慢性肾脏病甲状旁腺激素水平之间的种族差异。
J Bras Nefrol. 2021 Jan-Mar;43(1):34-40. doi: 10.1590/2175-8239-JBN-2020-0138.
10
Race and Ethnicity Predict Bone Markers and Fracture in Pediatric Patients With Chronic Kidney Disease.种族和民族预测慢性肾脏病儿科患者的骨标志物和骨折。
J Bone Miner Res. 2021 Feb;36(2):298-304. doi: 10.1002/jbmr.4182. Epub 2020 Oct 23.